Delivery Order SPE2DB22D3301-SPE2DB25FY7YA
Award Date 7/16/25
Potential Completion Date 8/6/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $11,830 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of SKYRIZI 360 mg/2.4 mL on-body injectors. The order, with an ultimate completion date of September 5, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. SKYRIZI is a biologic immunosuppressant used in the treatment of plaque psoriasis and other inflammatory conditions,...
- The Defense Logistics Agency awarded a $11,830.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body injectable medication on September 11, 2025. This non-set-aside contract is scheduled for completion by October 2, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. SKYRIZI is a biologic immunosuppressant used to treat moderate to severe plaque psoriasis and other inflammatory conditions,...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectable medication. This competitive award, issued on September 18, 2025, represents a firm fixed price delivery order with an ultimate completion date of October 9, 2025. The contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic...
- The Defense Logistics Agency awarded a $11,830 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body injector units on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a prescription biologic medication used to treat autoimmune conditions, and...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injectors. This firm fixed-price, competitively awarded contract was issued on July 29, 2025, with an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. SKYRIZI is a biologic immunosuppressant medication used in the treatment of moderate-to-severe plaque psoriasis...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11,830.00 on June 4, 2025, for the supply of SKYRIZI 360 mg/2.4 mL on-body injector units. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 26, 2025, to be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. SKYRIZI is a biologic immunosuppressant used to treat moderate to severe plaque psoriasis and other inflammatory conditions, and this...
- The Defense Logistics Agency awarded a delivery order valued at $12,467 to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body applicator units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 17, 2025, and was awarded on October 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic immunosuppressant medication used to treat moderate to severe plaque...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injection units, valued at $11.8K with a firm fixed price structure. This is a non-set-aside competitive award issued on August 13, 2025, with an ultimate completion date of September 4, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. SKYRIZI is a prescription biologic medication indicated for the treatment of...
- The Defense Logistics Agency awarded a $11,830 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body injector units, with a completion deadline of June 23, 2025. This non-competitive delivery order was awarded on May 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic medication used to treat inflammatory skin conditions, and this order represents a routine...
- The Defense Logistics Agency awarded a $11,830 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body applicators on August 26, 2025, with completion targeted for September 17, 2025. SKYRIZI is a biologic medication indicated for the treatment of plaque psoriasis and other inflammatory dermatological conditions. The award represents a competitively awarded, non-set-aside transaction executed through AmerisourceBergen's existing indefinite delivery...